126 related articles for article (PubMed ID: 34596208)
1. The novel function of citronellal for antidiabetic cardiomyopathy.
Qiu Y; Meng L; Chao C; Wang L; Wang Y; Liu T; Fu Y; Li Y; Song Y; Guo Y; Niu Q; Zhang J; Yin Y; Li P
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1731-1735. PubMed ID: 34596208
[No Abstract] [Full Text] [Related]
2. Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.
Park M; Nishimura T; Baeza-Garza CD; Caldwell ST; Pun PBL; Prag HA; Young T; Sauchanka O; Logan A; Forkink M; Gruszczyk AV; Prime TA; Arndt S; Naudi A; Pamplona R; Coughlan MT; Tate M; Ritchie RH; Caicci F; Kaludercic N; Di Lisa F; Smith RAJ; Hartley RC; Murphy MP; Krieg T
Cardiovasc Drugs Ther; 2020 Dec; 34(6):823-834. PubMed ID: 32979176
[TBL] [Abstract][Full Text] [Related]
3. Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway.
Liu ZW; Wang JK; Qiu C; Guan GC; Liu XH; Li SJ; Deng ZR
Acta Pharmacol Sin; 2015 Mar; 36(3):323-33. PubMed ID: 25619390
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats.
Hou J; Zheng D; Zhong G; Hu Y
Can J Physiol Pharmacol; 2013 Sep; 91(9):759-63. PubMed ID: 23984905
[TBL] [Abstract][Full Text] [Related]
5. Citronellal prevents endothelial dysfunction and atherosclerosis in rats.
Lu JX; Guo C; Ou WS; Jing Y; Niu HF; Song P; Li QZ; Liu Z; Xu J; Li P; Zhu ML; Yin YL
J Cell Biochem; 2019 Mar; 120(3):3790-3800. PubMed ID: 30367511
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy.
Gui C; Zhu L; Hu M; Lei L; Long Q
Cardiovasc Pathol; 2012; 21(5):414-20. PubMed ID: 22285193
[TBL] [Abstract][Full Text] [Related]
7. Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy.
Wang G; Li W; Lu X; Bao P; Zhao X
J Diabetes Complications; 2012; 26(4):259-65. PubMed ID: 22626874
[TBL] [Abstract][Full Text] [Related]
8. Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.
LaRocca TJ; Fabris F; Chen J; Benhayon D; Zhang S; McCollum L; Schecter AD; Cheung JY; Sobie EA; Hajjar RJ; Lebeche D
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H353-67. PubMed ID: 22610174
[TBL] [Abstract][Full Text] [Related]
9. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
[TBL] [Abstract][Full Text] [Related]
12. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
[TBL] [Abstract][Full Text] [Related]
13. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms for diastolic dysfunction in the human heart.
Czuriga D; Paulus WJ; Czuriga I; Édes I; Papp Z; Borbély A
Curr Pharm Biotechnol; 2012 Oct; 13(13):2532-8. PubMed ID: 22280428
[TBL] [Abstract][Full Text] [Related]
15. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
16. Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.
Wang L; Cai Y; Jian L; Cheung CW; Zhang L; Xia Z
Cardiovasc Diabetol; 2021 Jan; 20(1):2. PubMed ID: 33397369
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
19. Citronellal alleviates doxorubicin-induced cardiotoxicity by suppressing oxidative stress and apoptosis via Na
Liu X; Qiu Y; Huang N; Liu YH; Wang HH; Yu YN; Song YT; Wan GR; Wang SX; Li P; Yin YL
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22971. PubMed ID: 34813134
[TBL] [Abstract][Full Text] [Related]
20. Citronellal ameliorates doxorubicin-induced hepatotoxicity via antioxidative stress, antiapoptosis, and proangiogenesis in rats.
Liu X; Qiu Y; Liu Y; Huang N; Hua C; Wang Q; Wu Z; Lu J; Song P; Xu J; Li P; Yin Y
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22639. PubMed ID: 33051984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
